
Persephone Biosciences
Persephone Biosciences is a YC Winter 2018 (W18) company. Based in San Diego, CA, USA. Team of 6.
About Persephone Biosciences
Summary
Persephone Biosciences develops live biotherapeutic products targeting the gut microbiome, with a current focus on infant and toddler synbiotics. Its probiotic-prebiotic supplements replenish Bifidobacterium strains that are absent in the majority of babies today, replacing the guesswork of generic infant probiotics with clinically studied, strain-specific formulations validated in a randomized controlled trial.
Business model
Subscription purchase with promotional discounts for new customers
Go-to-market
Parents of infants and toddlers buy directly through the company's e-commerce store; healthcare practitioners are also addressed as a channel.
From the Y Combinator listing
We are using the gut microbiome to end cancer.
Persephone Biome develops live biotherapeutic products to modulate the metabolism of gut microbes, for applications in disease prevention and cure. We take a unique engineering approach using systems and synthetic biology to understand the complexities of the microbiome.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Diego, CA, USA
- 6
- Active
- Early
Founders (2)
- Stephanie Culler
- Stephen Van Dien
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works